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Abstract
Background: Small for gestational age (SGA) is frequently used to define fetal growth restriction (FGR). However, FGR
describes a slowdown in fetal growth and is not synonymous with SGA, which may introduce misclassification. We
investigated the effect of both on delivery and childhood outcomes.
Methods: From a prospective population-based cohort study we included 7959 live singleton births with data available
on second trimester estimated fetal weight (EFW) and birth weight. We used a decrease in growth of > 40 percentiles
between second trimester EFW and birthweight to define a deceleration in growth. SGA was defined as birthweight <p5.
Results: Deceleration of growth occurred in 27,2% in SGA neonates and in 10,3% of neonates with an appropriate for
gestational age (AGA) birthweight. Of all fetuses with decelerated growth, 90% was born AGA. SGA neonates were
more often delivered by instrumental delivery or cesarean section and admitted to NICU. Both decelerated growth and
SGA were associated with accelerated growth at 2 years, a smaller aortic diameter and lower left ventricular mass at
6 years.
Conclusions: Both decelerated growth and SGA are associated with unfavorable clinical outcomes in childhood. In
addition to SGA, neonates with deceleration of growth should be considered a high-risk group.
Keywords: Birth weight, Small for gestational age, Fetal growth restriction
Background
Fetal growth restriction (FGR) is considered a severe com-
plication of pregnancy associated with substantial peri-
natal morbidity and mortality and contributing to disease
in adulthood [1, 2]. The Development and Origins of
Health and Disease theory (DOHaD) states that in case of
adverse fetal exposure, the unborn fetus can modify its
own development such that it will be prepared for survival
in an environment in which resources are likely to be
short. Although these adaptations may be beneficial for
short term survival, they may have adverse consequences
at delivery or in later life [3]. FGR is difficult to assess as
the biological growth potential of the fetus can, at best, be
estimated and not directly measured. Therefore, in scien-
tific research FGR is frequently classified as a neonate
born small for gestational age (SGA). Yet, birth weight
and thus one single measurement can only indicate size.
Growth however is dynamic and can be measured only in
sequential measurements. Therefore FGR is not synonym-
ous with SGA. FGR fetuses may experience a failure to
reach their biological growth potential because of a patho-
logical slow-down (decelerating growth curve) in the fetal
growth pace. However, there is a lack of a uniform defin-
ition of decelerated growth and no golden standard exists.
This is highly warranted since it is estimated that approxi-
mately 50–70% of the SGA fetuses are constitutionally
small with normal perinatal outcomes [4, 5]. Growth vel-
ocity represents the rate of fetal growth in a specific time
interval and may have more clinical utility to distinguish
normal from pathological fetal growth and hence to iden-
tify fetal growth abnormalities.
In this study we assessed decelerating growth based on
the fetus individual growth curve, independent of birth
weight. We compared this method to small for gestation
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age (SGA) to determine whether growth velocity, independ-
ent of SGA, affects delivery outcomes, accelerated
growth in infancy and cardiovascular outcomes at the
age of 6 years.
Methods
This paper is a subset of the thesis of Dr. Broere-
Brown entitled Fetal sex dependency in pregnancy,
fetal and maternal outcomes (https://www.genera-
tionr.nl/wp-content/uploads/2017/10/PROEFS-
CHRIFT-ZA-BROERE-BROWN.pdf ).
Study design
The study was embedded in The Generation R Study, a
population-based prospective cohort study from early
pregnancy onwards [6]. All mothers with an expected
delivery date between April 2002 and January 2006 were
eligible. Response at baseline was 61%. The Medical Eth-
ics Committee (MEC) of the Erasmus Medical Center
Rotterdam, The Netherlands approved the study in 2001
(MEC 198.782/2001/31). Written informed consent was
obtained from all mothers. For the present study we in-
cluded pregnancies with a live born singleton birth with
a known second trimester estimated fetal weight (EFW)
and birth weight (N = 7959) (Fig. 1).
Fetal growth
To assess estimated fetal weight (EFW) ultrasound ex-
aminations were performed in the second trimester of
pregnancy (median 20.5 weeks of gestation, 90% range
18.9–22.9). Fetal biometry (head circumference [HC],
abdominal circumference [AC} and femur length [FL])
was measured trans abdominally. EFW was calculated
using the formula of Hadlock with parameters AC, HC
and FL (in cm): EFW = 10**(1.326–0.00326*AC*FL +
0.0107*HC + 0.0438*AC + 0.158*FL [7]. Ultrasound ex-
aminations were performed using Aloka® model SSD-
1700 (Tokyo, Japan) or the ATL-Philips® Model HDI
5000 (Seattle, WA, USA). SGA was defined as a gesta-
tional and fetal sex adjusted birth weight under the fifth
percentile (≤ 1.78 SD).
Both estimated fetal weight in the second trimester of
pregnancy and birth weight were presented in a gestational
age adjusted percentile. Since there is no definition of how
much a growth curve needs to decelerate before it can be
designated as a decelerating growth curve we used five cut-
Fig. 1 Flowchart
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offs to define decelerated growth; a decrease in growth of at
least 30, 35, 40, 45 or 50 percentiles respectively between
the second trimester and birth. This approach has been
suggested in previous studies and aims to approach a slow-
down in fetal growth. This slowdown is independent of the
actual birth weight. For example a fetus with an EFW of
p85 in the second trimester ending with a birth weight of
p35 has a growth deceleration of 50 percentiles but does
not meet the definition of SGA. However a fetus with an
EFW of p55 and a growth deceleration of 50 percentiles
ends with a birth weight of p5, which does meet the defin-
ition of SGA. We did not explore a decrease in growth of
less than 30 percentiles since these deviations in growth
could well be the results of measurement errors. The re-
sults using the cut-off of 40 percentiles are presented, re-
sults on the other cut-off values can be found in the
Supplementary materials. Choosing cut-offs to define decel-
erated growth may lead to misclassification. The initial esti-
mated fetal weight in the second trimester of pregnancy
should be above the 40th percentile. Otherwise the fetus is
not able to deviate from its growth curve with more than
40 percentiles. Therefore, in additional analyses we classi-
fied all fetuses with an EFW in the second trimester under
the 40th percentile and with a maximum decrease of
growth (birth weight under the first percentile) as deceler-
ated growth (n = 85).
Delivery outcomes
APGAR score at five minutes and delivery mode (spontan-
eous versus instrumental or emergency cesarean section)
were obtained from standardized delivery registrations of
midwives and obstetricians. An APGAR score below seven
after five minutes was considered low [8, 9]. Information
concerning admittance to the neonatal intensive care unit
(NICU) was obtained using hospital and national registries.
Infant growth
Well-trained staff in the Community Health Centers ob-
tained postnatal growth characteristics according to stand-
ard schedule and procedures at the age of 24months.
Standard deviation scores for childhood weight were ob-
tained with Dutch growth references charts (Growth
Analyzer 3.0; Dutch Growth Research Foundation, Rotter-
dam, the Netherlands). Postnatal accelerated growth was
defined as an increase between birth and 2 years of age in
their position on the age-specific weight distribution by at
least 0.67 SDS, representing the width of each percentile
band on a standard growth chart [10, 11].
Childhood cardiovascular outcomes
We invited all children to a dedicated research facility in
the Erasmus University Medical Center, Sophia Chil-
dren’s Hospital for detailed measurements at the age of
6 years (mean 6.2 ± 0.5) [6]. We measured height and
weight and calculated body mass index (BMI). Systolic
(SBP) and diastolic blood pressure (DBP) was measured
at the right brachial artery by using the validated auto-
matic sphygmomanometer Datascope Accutor Plus (Pa-
ramus, NJ, USA) [12]. We selected a cuff with a width
approximately 40% of the arm circumference and long
enough to cover 90% of the arm circumference.
Carotid-femoral pulse wave velocity (PWV) was
assessed by using the automatic Complior SP device
(Artech Medical, Pantin, France) with participants in su-
pine position. The distance between the recording sites
at the carotid (proximal) and femoral (distal) artery was
measured over the surface of the body to the nearest
centimeter. Through piezoelectric sensors placed on the
skin, the device collected signals to assess the time delay
between the upstroke of carotid and femoral waveforms.
Carotid-femoral pulse wave velocity (PWV) was calcu-
lated as the ratio of the distance traveled by the pulse
wave and the time delay between the waveforms, as
expressed in meters per second [13, 14]. To cover a
complete respiratory cycle, the mean of at least 10 con-
secutive pressure waveforms was used in the analyses.
PWV can be measured reliably with good reproducibility
in large pediatric population-based cohorts [14, 15].
Two-dimensional M-mode echocardiographic mea-
surements were performed using the ATL-Philips Model
HDI 5000 or the Logiq E9 (GE Medical Systems, Wau-
watosa, Wisconsin, USA) devises. Echocardiography was
used to measure the aortic root diameter (AOD), inter-
ventricular septum thickness in diastole (IVSTD), left
ventricular internal diameter in diastole (LVIDD) and
the left ventricular posterior wall thickness in diastole
(LVPWTD) using methods recommended by the Ameri-
can Society of Echocardiography [16]. Left ventricular
mass (LVM) was calculated using the formula derived by
Devereux et al.: LVM = 0.80 × 1.04 ((IVSTD + LVIDD +
LVPWTD) [3] – (LVIDD) [3]) + 0.6 [17, 18].
Covariates
Gestational age at birth and birth weight were obtained
from midwives and hospital registries. We obtained in-
formation on maternal age, ethnicity, educational level,
folic acid use and smoking in pregnancy by question-
naire at enrolment [6]. We measured first trimester ma-
ternal blood pressure with the validated oscillometric
sphygmomanometer (OMRON Healthcare Europe BV,
Hoofddorp, The Netherlands).
Statistical analyses
We examined the associations of decelerated growth and
a SGA with delivery outcomes and accelerated growth
after 2 years using logistic regression models. For the ana-
lyses on cardiovascular outcome measurements we con-
structed standard deviation score values ([observed value
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– mean] / SD) for the childhood cardiovascular outcome
measures to enable comparison of effect estimates for the
different outcomes. We did not create age adjusted stand-
ard deviation scores as the childhood outcomes were mea-
sured in a small age range and age of the child was
included as a covariate in all models. We used three differ-
ent linear and logistic regression models to examine the
associations of decelerated growth and SGA with infant
growth and childhood cardiovascular outcomes. Logistic
regression was used for the outcomes decelerated growth
and SGA. Childhood cardiovascular outcomes were ana-
lyzed with linear regression models. The basic model was
adjusted for child’s sex, age and ethnicity. The confounder
model was additionally adjusted for maternal age, maternal
educational level, smoking in pregnancy and folic acid use.
We selected these confounders on the basis of their associ-
ations with both the exposure and the outcome of interest
and / or a change in effect estimate of more than 10%. We
considered the confounder model to be the main model.
Since the group of FGR fetuses is a mixed population
with both AGA and SGA fetuses, we wanted to exclude
the possibility that the effect of FGR depends on being
SGA. Therefore effect modification was tested on the
multiplicative scale. If p < 0.10 was fulfilled regression
analyses concerning FGR were performed in strata; SGA
fetuses and AGA fetuses.
For all analyses, the percentages of missing values of
covariates were lower than 20%. An overview of which
covariates were used in the model and their percentage
missing is presented in Additional file 1: Table S1. We
imputed missing data of the covariates by using multiple
imputations [19]. Ten datasets were created and ana-
lyzed together. Statistical analyses were performed using
the Statistical Package of Social Sciences version 21.0 for
Windows (IBM Corp., Armonk, NY, USA).
Results
Baseline characteristics
Baseline characteristics are shown in Table 1. SGA fe-
tuses had a mean birth weight of 2484 ± 402 g (1.7th per-
centile) while fetuses with a decelerated growth had a
mean birth weight of 2992 ± 383 g (21.5th percentile).
Gestational age at birth was comparable between SGA
fetuses and fetuses with a growth deceleration (39,9 [35,
Table 1 Baseline characteristics
Total study-population DG SGA
n = 7959 n = 958 n = 408
Maternal age 29,7 (5,2) 28,9 (5,6) 29,1 (5,7)
Anthropometrics
Height (cm) 167,2 (7,4) 165,8 (7,1) 164,0 (7,0)
Weight (kg) 69,3 (13,3) 68,0 (13,0) 63,8 (12,5)
BMI (kg/m2) 23,8 (19,3 - 33,6) 23,7 (19,0 - 34,1) 22,7 (18,4 - 31,6)
Ethnicity
Non-Western 3171 (41,7%) 423 (46,6%) 206 (53,4%)
Educational level
Low 971 (12,2%) 133 (13,9%) 55 (13,5%)
Smoking habits
Yes - continued 1482 (18,6%) 237 (24,7%) 130 (31,9%)
Folic acid use - Yes (%)
No 2382 (29,9%) 340 (35,5%) 151 (37,0%)
Nulliparous (%) 4470 (56,2%) 610 (63,7%) 289 (70,8%)
Gestational age at birth (wks) 40,1 (37,0 - 42,0) 39,7 (36,6 - 41,6) 39,9 (35,9 - 41,9)
Preterm birth < 37 wks (%) 297 (3,7%) 37 (3,9%) 11 (2,7%)
Birthweight (g) 3412 (560) 2992 (383) 2484 (402)
Birthweight (percentile) 47,1 (28,7) 21,5 (14,8) 1,72 (1,14)
Placenta weight (gr) 620 (415–900) 555 (380–769) 480 (300–678)
Ratio placenta / birthweight 0,19 (0,04) 0,19 (0,04) 0,20 (0,04)
Pre-eclampsia (%) 157 (2,1%) 36 (4,2%) 32 (8,7%)
Sex (n, % male) 4005 (50,3%) 477 (49,8%) 222 (54,4%)
Data are represented as n (%) or as the mean (SD) or as the median (90% range)
Decelerated growth (DG) was defined as a decrease in growth of at least 40 percentiles between the second trimester and birth
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9 – 41,9] wks versus 39,7 [36,6 – 41,6] wks). Compared
with growth-decelerated fetuses, the mothers of SGA fe-
tuses were more often nulliparous, of non-Western des-
cent and smokers.
Using the definition of a decrease in fetal growth of at
least 40 percentiles, of all SGA fetuses 96 (23.5%) had
decelerated growth. Of the AGA fetuses, 862 (11.4%) ex-
perienced decelerated growth. Of all fetuses with a de-
celerated growth, 90% was born AGA.
Delivery outcomes
All results on birth outcomes are presented in Fig. 2.
Neonates without growth deceleration and with a nor-
mal birth weight were used as a reference category and
compared with neonates with SGA or a growth deceler-
ation of 40 percentiles (DG 40). No associations were
found between decelerated growth and delivery out-
comes. However, SGA was associated with a lower risk
of a low APGAR score after 5 min (OR 0.37 [95% CI
0.16;0.83]) but increased risks of an instrumental deliv-
ery (OR 1.47 [95% CI 1.05;2.07]), an emergency cesarean
section (OR 1.93 [95% CI 1.29;2.88]) and NICU admit-
tance (OR 4.21 [95% CI 3.12;5.67]) compared to AGA
neonates (Fig. 2).
Accelerated growth
All results on accelerated growth are presented in Fig. 3.
Neonates without growth deceleration and with a normal
birth weight were used as a reference category and com-
pared with neonates with SGA or a growth deceleration of
40 percentiles (DG 40). Children born SGA had an in-
creased risk of accelerated growth at the age of 2 years
(OR 7.93 [95% CI 4.63;13.60]). However, decelerated
growth was associated with an increased risk of acceler-
ated growth at the age of 2 years (OR 2.86 [95% CI 2.17–
3.76] compared to non-decelerated growth fetuses.
Cardiovascular outcomes at the age of 6 years
All results on cardiovascular outcomes are presented in
Table 2. Neonates without growth deceleration and with
a normal birth weight were used as a reference category
and compared with neonates with SGA, neonates with a
growth deceleration (DG) and specifically neonates with
a growth deceleration but a normal birth weight (DG –
no SGA). Both SGA neonates as well as neonates with
decelerated growth had a lower BMI (− 0.29 SD [95% CI
− 0.17;− 0.41] vs (− 0.16 SD [95% CI-0.24;-0.08]), a
smaller aortic root diameter (− 0.37 SD [95% CI -0.49;-
0.25] vs (− 0.14 SD [95% CI-0.22;-0.06]) and lower left
ventricular mass (− 0.36 SD [95% CI -0.48;-0.24] vs 0.15
SD [95% CI -0.23;-0.07]) at the age of 6 years compared
to AGA neonates (Table 2).
When restricting the analyses to neonates who experi-
enced a decelerated growth with a normal birth weight (i.e.
DG – AGA) the results were comparable. Results on deliv-
ery outcomes, accelerated growth and cardiovascular
Fig. 2 Logistic regression analyses on birth outcomes
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outcomes using the other cut-offs for defining decel-
erated growth are depicted in Additional file 2: Figure
S1, Additional file 3: Figure S2 and Additional file 4:
Figure S3 respectively.
For all outcomes no effect modification was found be-
tween decelerated growth and SGA. Our additional ana-
lyses in which we classified all fetuses with an EFW in
the 2nd trimester under the 40th percentile and with a
maximum decrease of growth (birth weight under the
1st percentile) as decelerated growth, showed that all the
effect estimates remained the same. We concluded that
potential misclassification did not affect out results. We
decided to continue with the original definition i.e. a de-
crease of growth of at least 40 percentiles.
Discussion
Main findings
This study shows that both SGA as well as decelerated
growth are associated with accelerated growth at the age
of 2 years and altered cardiovascular measurements at the
age of six. The effect estimates of the observed associa-
tions were higher for SGA than for decelerated growth.
Most interestingly, substantial associations were found be-
tween fetuses with a decelerated growth but a normal
birth weight, and accelerated growth at the age of 2 years
and cardiovascular outcomes at the age of 6 years.
Strengths and limitations
The main strength of this study was the extensive pro-
spective data collection on fetal growth, childhood
health and environmental influences. This enabled us to
adjust for multiple confounding factors and investigate
the effects of fetal growth on three different time points
(i.e. at delivery and at the age of two and 6 years) in a
large sample of 7959 participants.
Follow-up data at 6 years was available in 65% of our
study population. Those who were not included in the
study were more frequently lower educated, had a higher
prevalence of multiparity, smoked more often and used
less often folic acid during pregnancy (Additional file 5:
Table S2). A more healthy population was therefore in-
cluded in our study which might have introduced a selec-
tion bias and may affect the generalizability of our results.
Estimation of fetal weight with ultrasound and the
Hadlock formula has a mean absolute error of 8–13%
dependent of the size of the fetus [20]. However, there is
a risk of overestimation in pregnancies with suspected
large for gestational age (LGA) fetuses and an underesti-
mation in pregnancies with suspected SGA [21]. Since
the definition of decelerated growth used in this study is
based on the percentiles of EFW this may have led to
misclassification. In that case the associations between
decelerated growth and our outcomes would have been
biased towards the null. Hence, our associations might
reflect underestimations. Moreover deviations in growth
could also result from random measurement errors of
the ultrasound technique. Therefore we decided to not
explore a decrease in growth of less than 30 percentiles
with the disadvantage that it is challenging to classify a
fetus as a growth decelerated fetus if the EFW in the
second trimester is p40 or below.
Since we assessed EFW in the second trimester of
pregnancy a possible growth deceleration before the
20th week of gestation was not assessed and there-
fore missed. In the case of early growth deceleration
with a normal growth in the second and third tri-
mester of pregnancy this could have led to misclassi-
fication. A fetus would wrongfully be assigned to the
group without deceleration, which would underesti-
mate our results.
Fig. 3 Logistic regression analyses on accelerated growth
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Interpretation
One of the key findings of this study is that neonates
with a decelerating growth curve have in an increased
risk of accelerated growth and altered cardiovascular
outcomes at the age of 6 years despite the fact that 90%
of decelerated growth neonates are born AGA. In this
study, we defined decelerated growth independent of
birth weight or other measurements during pregnancy
such as a fetal abdominal circumference under the 5th
percentile, the pulsatility index of the umbilical or the
middle cerebral artery or biomarkers. Since there is no
consensus on how much a growth curve needs to devi-
ate before it can be designated as a deviating growth
curve several cut-offs were used based on a decrease in
growth expressed in percentiles. A disadvantage of this
approach is that the change in weight per percentile is
not constant but increases towards the more sparsely
populated extremes of a distribution. Hence, a fetus ini-
tially at the 90th percentile of a weight distribution and
ending at the 50th percentile is, expressed in estimated
fetal weight, more growth decelerated compared with a
fetus initially at the 70th percentile and ending at the
Table 2 Associations between decelerated growth (DG) and cardiovascular outcomes
Basic model Confounder model Childhood pathway
β (95% CI) p-value β (95% CI) p-value β (95% CI) p-value
BMI (SD)
No DG + no SGA reference reference NA
DG 40 -0,12 (−0,20;-0,06) 0,002 -0,16 (− 0,24;-0,08) < 0,001
DG 40 (AGA) −0.09 (− 0.17;0.01) 0.01 − 0.15 (− 0.23;− 0.07) 0.001
SGA − 0,23 (− 0,36;− 0,12) < 0,001 -0,29 (− 0,17;-0,41) < 0,001
Systolic blood pressure (SD)
No DG + no SGA reference reference reference
DG 40 0,02 (−0,06;0,11) 0,66 -0,00 (−0,09;0,08) 0,93 0,03 (−0,06;0,11) 0,56
DG 40 (AGA) 0.01 (−0.08;0.09) 0,91 −0.01 (− 0.10;0.08) 0.85 0.04 (− 0.05;0.12) 0.71
SGA 0,12 (−0,01;0,25) 0,07 0.07 (−0.05;0.20) 0.26 0.13 (0.00;0.26) 0,04
Diastolic blood pressure (SD)
No DG + no SGA reference reference reference
DG 40 0,07 (−0,02;0,15) 0,13 0,04 (−0,04;0,13) 0,24 0,06 (−0,03;0,14) 0,18
DG 40 (AGA) 0.06 (−0.05;0.17) 0.19 0.05 (−0.04;0.14) 0.30 0.05 (−0.04;0.14) 0.24
SGA 0.15 (0.02;0.28) 0.02 0.12 (−0.01;0.25) 0.06 0.16 (0.03;0.28) 0.02
Aortic root diameter (SD)
No DG + no SGA reference reference reference
DG 40 −0,14 (−0,23;− 0,08) 0,001 − 0,14 (− 0,22;-0,06) 0,001 -0,10 (− 0,18;-0,03) 0,01
DG 40 (AGA) − 0.12 (− 0.21;-0.04) 0.008 −0.12 (− 0.20;-0.03) 0.007 −0.08 (− 0.16;0.00) 0.06
SGA −0,39 (− 0,50;− 0,27) < 0,001 −0,37 (− 0,49;− 0,25) < 0,001 −0,33 (− 0,44;− 0,21) < 0,001
Left ventricular mass (SD)
No DG + no SGA reference reference reference
DG 40 -0,17 (−0,25;-0,09) < 0,001 -0,15 (−0,23;-0,07) < 0,001 -0,11 (− 0,19;-0,04) 0,004
DG 40 (AGA) −0.15 (− 0.24;-0.07) 0.001 − 0.14 (− 0.23;-0.06) 0.001 −0.09 (− 0.17;− 0.01) 0.03
SGA −0,35 (− 0,23;− 0,47) < 0,001 −0,36 (− 0,48;− 0,24) < 0,001 −0,30 (− 0,41;− 0,19) < 0,001
Pulse wave velocity (SD)
No DG + no SGA reference reference reference
DG 40 0,00 (−0,09;0,10) 0,93 0,00 (−0,09;0,09) 0,97 -0,01 (−0,10;0,09) 0,89
DG 40 (AGA) 0.03 (−0.07;0.12) 0.57 0.03 (−0.07;0.12) 0.60 0.02 (−0.08;0.12) 0.70
SGA -0,05 (−0,19;0,09) 0,48 -0,05 (−0,19;0,09) 0,47 -0,07 (−0,21;0,07) 0,35
Values are regression coefficient with the 95% CI and are based on linear regression models
Basic model: Adjusted child’s sex, visit interval and child’s ethnicity
Confounder model: Basic model and additionally adjusted for maternal age, educational level, smoking, folic acid intake and diastolic blood pressure at intake
Childhood pathway model: Confounder model and additionally adjusted for child’s current body mass index
Abbreviations: AGA Appropriate for gestational age birth weight, DG 40 decelerated growth of 40 percentiles, CI confidence interval, NA not applicable
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30th percentile. Only a portion of the neonates born
small for gestational age had decelerated growth, ranging
from 15.9 to 32.8% depending on the used cut-off. The
fact that the group of SGA fetuses is a heterogeneous
group consisting out of fetuses that are constitutionally
small, and fetuses with a growth deceleration is well
known and accepted. In previous research on SGA dif-
ferent attempts were made in trying to stratify these two
groups by calculating the ponderal index, use the birth
weight of a sibling as a reference, or the usage of cus-
tomized charts or prediction models [22–28]. However,
in all these studies attention was solely focused on SGA
neonates in whom decelerated growth is merely a form
of SGA. Neonates born AGA are not subject of investi-
gation whereas this study shows that 88.9 to 90.7% of
the neonates with a growth deceleration were born AGA
and that from all AGA born fetuses 6.9 to 17.4% is in
fact growth decelerated. Despite these high percentages
substantial associations between decelerated growth and
accelerated growth and altered cardiovascular measure-
ments during childhood were found. Already during
pregnancy fetuses with a decelerating growth curve have
a higher pulsatility index of the umbilical artery com-
pared with fetuses without a growth restriction (p < 0.01)
. A sensitivity analyses was performed repeating the ana-
lysis in only growth-decelerated fetuses born AGA,
which gave the same results (data not shown). This indi-
cates that growth decelerated neonates born AGA
should be considered as a high risk group with more
emphasize needed in future research.
The effect estimates of the associations on accelerated
growth at the age of two and cardiovascular measure-
ments at the age of six were higher for SGA children com-
pared with those with growth deceleration. One might
hypothesize that this implies that birth weight, the end-
point of a growth pattern, is more important than the
growth pattern itself. However, it could also be that the ef-
fects are not measurable yet in case the fetus did not reach
a certain lower limit of birth weight (i.e. a threshold effect)
. The difference in birth weight between SGA neonates
and neonates with a growth deceleration could explain
why associations were found with delivery outcomes for
SGA neonates but not for growth decelerated neonates.
SGA neonates were more often delivered by an emergency
cesarean section or an instrumental delivery compared
with growth-decelerated neonates. Due to their low birth
weight SGA neonates are more prone to experience fetal
distress with as consequence an increased risk of seizures,
respiratory diseases, hypoglycemia and hyperbilirubinemia
with admittance at the NICU compared with their AGA
counterparts [29]. This foresight could have influenced
the practicing physician by lowering the threshold when
to perform an emergency cesarean section. This would
also explain why preterm birth before 37 weeks of
gestation occurs more often in SGA fetuses compared
with growth decelerated fetuses (3.9% vs 2.7%, Table 1).
Partly this will be iatrogenic due to the knowledge that the
fetus is SGA. This tendency to intervene earlier might be
an explanation why SGA neonates more often are deliv-
ered by vaginal instrumental delivery or cesarean section,
in the presence but perhaps also absence of non-
reassuring fetal heart rate monitoring, but less often have
an APGAR score below seven after 5min. This is not the
case for FGR fetuses since the majority of these fetuses
were born AGA. However, in the neonatal model in which
we additionally adjusted for birth weight the effect on
emergency cesarean section and admittance at the NICU
department remains significant, meaning that other fac-
tors besides birth weight are of importance.
Both growth deceleration as well as SGA was associ-
ated with an increased risk of accelerated growth in the
first 2 years of life. Accelerated growth is associated with
obesity in later life giving rise to impaired cardiovascular
health [30]. Especially in those born with a low birth
weight [31, 32]. This is in line with our study in which
the SGA neonates, who had a higher risk of accelerated
growth compared with the growth decelerated neonates,
also had poorer cardiovascular outcomes. One could
also explain the associations between SGA and cardio-
vascular outcomes by body size since children born SGA
often have a lower BMI compared with their peers.
Growth deceleration is not limited to mid and late preg-
nancy only. Embryonic growth and development during
the first trimester of pregnancy is essential for organogen-
esis of the fetal cardiovascular system. Impaired early
growth has also been shown to be associated with an ad-
verse cardiovascular risk profile in children at the age of
6 years [33, 34]. If fetal growth restriction occurs in early
pregnancy, gestational age is often adjusted according to
the crown-rum-length. After adjustment fetal growth may
seem appropriate although the neonate should have been
classified as being SGA with the long-term sequalae as
shown in this article. Therefore more attention is needed
for fetal growth restriction throughout gestation and not
only during the second half of pregnancy.
Not only SGA neonates but also growth decelerated
neonates with a normal birth weight had a different car-
diovascular profile at the age of 6 years as shown by dif-
ferences in the aortic root diameter and left ventricular
mass. It is well established that low birth weight is asso-
ciated with poor cardiovascular health in later life but
the fact that also growth pattern is a risk factor inde-
pendent of birth weight is an important finding. A
smaller aortic root diameter is associated with ventricu-
lar outflow obstruction and possibly the development of
hypertension in later life. While it is different to relate
these measurement to exact cardiac function in later
adult life, our findings strongly suggest that growth
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decelerated neonates despite their normal birth weight
already have a less optimal cardiovascular profile which
warrants follow-up and further investigation.
Conclusion
In this study in which we explored differences in out-
come between SGA and growth decelerated fetuses, we
observed that fetuses with a decelerated growth curve
but nevertheless are born AGA constitute a vulnerable
group with increased risks of accelerated growth and al-
tered cardiovascular outcomes in childhood and in their
future lives. Future research should be focused on this
particular group since these newborns are now, focusing
on only a birthweight < p10, not classified as such and
are not subject to any follow up in future life.
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